Page last updated: 2024-09-05

lapatinib and (1R,2S)-tranylcypromine hydrochloride

lapatinib has been researched along with (1R,2S)-tranylcypromine hydrochloride in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
((1R,2S)-tranylcypromine hydrochloride)
Trials
((1R,2S)-tranylcypromine hydrochloride)
Recent Studies (post-2010) ((1R,2S)-tranylcypromine hydrochloride)
1,9193051,44226014

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)(1R,2S)-tranylcypromine hydrochloride (IC50)
trace amine-associated receptor 1Homo sapiens (human)2.097
Lysine-specific histone demethylase 1AHomo sapiens (human)2.1
Amine oxidase [flavin-containing] AHomo sapiens (human)4.5
Amine oxidase [flavin-containing] BHomo sapiens (human)2.8117

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1

Other Studies

1 other study(ies) available for lapatinib and (1R,2S)-tranylcypromine hydrochloride

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010